scholarly article | Q13442814 |
P50 | author | Youngkeun Ahn | Q87419336 |
P2093 | author name string | Ju Han Kim | |
Myung Ho Jeong | |||
Sang Rok Lee | |||
Jeong Gwan Cho | |||
Jong Chun Park | |||
Jung Chaee Kang | |||
Kye Hun Kim | |||
Young Joon Hong | |||
Hyung Wook Park | |||
Weon Kim | |||
Seo Na Hong | |||
P2860 | cites work | Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis | Q28187825 |
Intracoronary radiation therapy | Q34207347 | ||
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty | Q34336722 | ||
Drug-eluting stents: cost versus clinical benefit | Q35160536 | ||
Drug-eluting stents: costs versus clinical benefit | Q35160541 | ||
Hippocrates revisited: the evidence for drug-eluting stents | Q35160546 | ||
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). | Q36728740 | ||
A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies | Q37638598 | ||
Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications | Q38648794 | ||
Local drug delivery for the prevention of restenosis. Fact, fancy, and future | Q40630968 | ||
Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease | Q41017012 | ||
7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1. | Q41123265 | ||
Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model | Q43727885 | ||
Pathological analysis of local delivery of paclitaxel via a polymer-coated stent | Q43978575 | ||
Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent | Q44072451 | ||
Systemic drug therapy for restenosis: "déjà vu all over again". | Q44196687 | ||
Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study). | Q44244528 | ||
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization | Q44612131 | ||
Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model | Q45014996 | ||
Low molecular weight heparin in prevention of restenosis after angioplasty. Results of Enoxaparin Restenosis (ERA) Trial | Q47371323 | ||
Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): report from the National Heart, Lung, and Blood Institute PTCA Registry. | Q50584299 | ||
The clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (abciximab: ReoPro)-coated stent in acute myocardial infarction. | Q51253557 | ||
Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting. | Q51315113 | ||
Effect of abciximab-coated stent on in-stent intimal hyperplasia in human coronary arteries. | Q51600960 | ||
Pathology of Acute and Chronic Coronary Stenting in Humans | Q58492259 | ||
A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI) | Q64948282 | ||
Intimal hyperplasia as a cause of restenosis after percutaneous transluminal coronary angioplasty | Q67278737 | ||
Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty | Q67299486 | ||
Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model | Q67733219 | ||
Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils | Q68499801 | ||
Preventive effects of the heparin-coated stent on restenosis in the porcine model | Q73091870 | ||
Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months | Q73321703 | ||
Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen | Q73356312 | ||
Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study | Q73368849 | ||
In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia | Q74027568 | ||
Selective alpha v beta 3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: evidence for the functional importance of integrin alpha v beta 3 and osteopontin expression during n | Q74422055 | ||
Comparison of the heparin coated vs the uncoated Jostent--no influence on restenosis or clinical outcome | Q74493440 | ||
Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty | Q77958677 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P921 | main subject | inflammation | Q101991 |
coronary restenosis | Q18556246 | ||
P304 | page(s) | 802-809 | |
P577 | publication date | 2007-10-01 | |
P1433 | published in | Journal of Korean Medical Science | Q24039955 |
P1476 | title | Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model | |
P478 | volume | 22 |
Q37316783 | A bumpy and winding but right path to domestic drug-eluting coronary stents |
Q33634727 | A novel stent coated with antibodies to endoglin inhibits neointimal formation of porcine coronary arteries |
Q35535453 | Comparison of reendothelialization and neointimal formation with stents coated with antibodies against endoglin and CD34 in a porcine model |
Q30278668 | Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics |
Q42262004 | Development of Novel Drug-Eluting Stents for Acute Myocardial Infarction |
Q35215336 | Effect of pretreatment of ezetimibe/simvastatin on arterial healing and endothelialization after drug-eluting stent implantation in a porcine coronary restenosis model |
Q36078220 | Impact of heterogeneous overlapping drug-eluting stents on the arterial responses of rabbit iliac arteries: a comparison with overlapping bare metal stents |
Q37011736 | Integrin αIIbβ3: from discovery to efficacious therapeutic target |
Q37872741 | Stents as a platform for drug delivery |
Q58691736 | Targeted Treatments for Restenosis and Vein Graft Disease |